Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Shaw on #NYSEFloorTalk to talk about their innovative obesity drug, ARD-101. He shared how it stands out from other treatments, the encouraging data so far, and what their upcoming trials will focus on.
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Khan Shaw on #NYSEFloorTalk to talk about their innovative obesity drug, ARD-101. He shared how it stands out from other treatments, the encouraging data so far, and what their upcoming trials will focus on.